Rittenhouse Ventures sees a significant increase in assets under management, now surpassing $75 million, following the successful closure of Fund III.
Rittenhouse Ventures Strengthens Capacity with New Partners
Rittenhouse Ventures, a venture capital firm based in the United States, has announced the addition of two experienced partners, David Nevas and Sushma Rajagopalan, to its team. This move is aimed at strengthening the firm's capacity to source, grow, and exit high-potential companies.
Founded by Saul Richter in 2018, Rittenhouse Ventures continues to focus on investing in capital-efficient, innovative B2B software, AI, and tech-enabled services companies. The geographical focus of Fund III remains on the Mid-Atlantic and other underserved regions across the United States.
Saul Richter, the Founder & Managing Partner of Rittenhouse Ventures, expressed his enthusiasm about supporting scalable businesses. He acknowledged the ability of management teams to scale businesses through various market conditions and highlighted the challenge of building early-stage companies into category leaders.
David Nevas, with nearly 20 years of experience in technology investing, and Sushma Rajagopalan, who brings over 30 years of operating leadership experience in the tech sector, are expected to play significant roles in achieving this goal.
Fund III has already made initial investments in GoMo Health, Pieces Technologies, WealthHub Solutions, and High QA. Notable previous investments by Rittenhouse Ventures include Tabula Rasa HealthCare, AppsFlyer, Prosperoware, GSI Health, Piano Software, and Halfpenny Technologies.
With these initial investments, Rittenhouse Ventures has made over 30 investments in total. The firm has also made over 20 exits, demonstrating its success in identifying and nurturing high-potential companies.
Ongoing capital deployment for Fund III will be directed towards new promising businesses. Nearly half of Rittenhouse Ventures' investments focus on Healthcare IT, reflecting the firm's commitment to this sector.
Rittenhouse Ventures has closed Fund III, with over $75 million of assets under management. The firm looks forward to continuing its mission of supporting scalable businesses and helping them grow into category leaders.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant